Pharma body opposes entry curbs on medical representatives, seeks rethink
Indian pharma firms not copying products, India respect IP rights, says Goyal Regulator set to monitor antimicrobial resistance Glenmark to launch DCGI-approved cancer drug in India - Advent International to acquire stake in Felix Pharmaceuticals
- Weight-loss drug bulks up sales as patients upgrade dosage
- API prices fall sharply, easing pressure on India's pharmaceutical industry
- Dr Reddy’s, Alvotech to co-develop Keytruda biosimilar
- Wockhardt eyes USD 7 billion market opportunity for antibiotic Zaynich in US, Europe
- Murae Organisor board to consider bonus issue, dividend payout next week
- Zydus to acquire US biotech firm Agenus’ facilities in California
- Trump’s prescription drug price cuts unlikely to hit Indian pharma exports significantly: Crisil Ratings
- Biocon gets CDSCO nod for generic diabetes medication
- Heart of the matter: Sales of cardiac drugs beat stronger
- Glenmark’s blood cancer drug ISB 2001 shows promising results in trial
ADVERTISEMENT